WO2018134232A1 - Dispositif maldi et procédés de préparation et d'utilisation associés - Google Patents
Dispositif maldi et procédés de préparation et d'utilisation associés Download PDFInfo
- Publication number
- WO2018134232A1 WO2018134232A1 PCT/EP2018/051080 EP2018051080W WO2018134232A1 WO 2018134232 A1 WO2018134232 A1 WO 2018134232A1 EP 2018051080 W EP2018051080 W EP 2018051080W WO 2018134232 A1 WO2018134232 A1 WO 2018134232A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nanoparticles
- maldi
- plate
- intact
- biological entities
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 25
- 238000002360 preparation method Methods 0.000 title description 3
- 239000002105 nanoparticle Substances 0.000 claims abstract description 39
- 239000011159 matrix material Substances 0.000 claims abstract description 29
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 23
- 239000000758 substrate Substances 0.000 claims abstract description 23
- 238000004949 mass spectrometry Methods 0.000 claims abstract description 21
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 17
- 238000003795 desorption Methods 0.000 claims abstract description 12
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 6
- 150000002632 lipids Chemical class 0.000 claims abstract description 3
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 claims description 66
- 238000001514 detection method Methods 0.000 claims description 24
- 241000894006 Bacteria Species 0.000 claims description 22
- 206010028980 Neoplasm Diseases 0.000 claims description 16
- 201000011510 cancer Diseases 0.000 claims description 16
- 229910044991 metal oxide Inorganic materials 0.000 claims description 9
- 244000005700 microbiome Species 0.000 claims description 9
- 229910001220 stainless steel Inorganic materials 0.000 claims description 9
- 239000010935 stainless steel Substances 0.000 claims description 9
- 239000000725 suspension Substances 0.000 claims description 9
- 241000700605 Viruses Species 0.000 claims description 8
- 150000004706 metal oxides Chemical class 0.000 claims description 8
- 241000233866 Fungi Species 0.000 claims description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 230000003115 biocidal effect Effects 0.000 claims description 6
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 4
- XOLBLPGZBRYERU-UHFFFAOYSA-N SnO2 Inorganic materials O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 claims description 4
- MCMNRKCIXSYSNV-UHFFFAOYSA-N ZrO2 Inorganic materials O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 claims description 4
- 239000004411 aluminium Substances 0.000 claims description 4
- 229910052782 aluminium Inorganic materials 0.000 claims description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 238000007639 printing Methods 0.000 claims description 4
- 239000006096 absorbing agent Substances 0.000 claims description 3
- 239000002800 charge carrier Substances 0.000 claims description 3
- 238000000151 deposition Methods 0.000 claims description 3
- 229910052737 gold Inorganic materials 0.000 claims description 3
- 229910052709 silver Inorganic materials 0.000 claims description 3
- 238000005245 sintering Methods 0.000 claims description 3
- 229920001940 conductive polymer Polymers 0.000 claims description 2
- 238000007641 inkjet printing Methods 0.000 claims description 2
- 239000002207 metabolite Substances 0.000 claims description 2
- 150000002739 metals Chemical class 0.000 claims description 2
- 229910052759 nickel Inorganic materials 0.000 claims description 2
- 102000039446 nucleic acids Human genes 0.000 claims description 2
- 108020004707 nucleic acids Proteins 0.000 claims description 2
- 150000007523 nucleic acids Chemical class 0.000 claims description 2
- 238000007650 screen-printing Methods 0.000 claims description 2
- -1 Ί1Ο2 Chemical class 0.000 claims description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 1
- 238000005266 casting Methods 0.000 claims 1
- 229910052802 copper Inorganic materials 0.000 claims 1
- 239000010949 copper Substances 0.000 claims 1
- 239000011521 glass Substances 0.000 claims 1
- MRNHPUHPBOKKQT-UHFFFAOYSA-N indium;tin;hydrate Chemical compound O.[In].[Sn] MRNHPUHPBOKKQT-UHFFFAOYSA-N 0.000 claims 1
- 229910052710 silicon Inorganic materials 0.000 claims 1
- 239000010703 silicon Substances 0.000 claims 1
- 229910052725 zinc Inorganic materials 0.000 claims 1
- 239000011701 zinc Substances 0.000 claims 1
- 238000004458 analytical method Methods 0.000 abstract description 12
- 238000001906 matrix-assisted laser desorption--ionisation mass spectrometry Methods 0.000 abstract description 7
- 238000007348 radical reaction Methods 0.000 abstract description 5
- 230000027756 respiratory electron transport chain Effects 0.000 abstract description 4
- 239000003504 photosensitizing agent Substances 0.000 abstract description 3
- 210000004027 cell Anatomy 0.000 description 24
- 239000000523 sample Substances 0.000 description 22
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 description 17
- 241000588724 Escherichia coli Species 0.000 description 16
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapic acid Chemical compound COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 description 15
- 238000001819 mass spectrum Methods 0.000 description 14
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 10
- 229960000723 ampicillin Drugs 0.000 description 7
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 7
- 239000003242 anti bacterial agent Substances 0.000 description 7
- 229940088710 antibiotic agent Drugs 0.000 description 7
- 239000005090 green fluorescent protein Substances 0.000 description 7
- 229930027917 kanamycin Natural products 0.000 description 7
- 229960000318 kanamycin Drugs 0.000 description 7
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 7
- 229930182823 kanamycin A Natural products 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000012472 biological sample Substances 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 5
- AFVLVVWMAFSXCK-VMPITWQZSA-N alpha-cyano-4-hydroxycinnamic acid Chemical compound OC(=O)C(\C#N)=C\C1=CC=C(O)C=C1 AFVLVVWMAFSXCK-VMPITWQZSA-N 0.000 description 5
- 230000005660 hydrophilic surface Effects 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 5
- 201000001441 melanoma Diseases 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000000090 biomarker Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000001699 photocatalysis Effects 0.000 description 4
- 238000006479 redox reaction Methods 0.000 description 4
- 235000014469 Bacillus subtilis Nutrition 0.000 description 3
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 3
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010034133 Pathogen resistance Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 239000002086 nanomaterial Substances 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 2
- 229930182566 Gentamicin Natural products 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229960003669 carbenicillin Drugs 0.000 description 2
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 229960005091 chloramphenicol Drugs 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 2
- 238000003759 clinical diagnosis Methods 0.000 description 2
- 239000004020 conductor Substances 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 238000000132 electrospray ionisation Methods 0.000 description 2
- 229960003276 erythromycin Drugs 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229960002518 gentamicin Drugs 0.000 description 2
- 239000012478 homogenous sample Substances 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000000752 ionisation method Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 238000007146 photocatalysis Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229960000268 spectinomycin Drugs 0.000 description 2
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 description 1
- CDWGDLKZKCYUFO-UHFFFAOYSA-N 6-(trifluoromethyl)-1h-indole-2-carboxylic acid Chemical compound C1=C(C(F)(F)F)C=C2NC(C(=O)O)=CC2=C1 CDWGDLKZKCYUFO-UHFFFAOYSA-N 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 108010015899 Glycopeptides Proteins 0.000 description 1
- 102000002068 Glycopeptides Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 108010013639 Peptidoglycan Proteins 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 241000607734 Yersinia <bacteria> Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000005030 aluminium foil Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000004666 bacterial spore Anatomy 0.000 description 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 239000000412 dendrimer Substances 0.000 description 1
- 229920000736 dendritic polymer Polymers 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000014670 detection of bacterium Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 238000005040 ion trap Methods 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000003641 microbiacidal effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229940031182 nanoparticles iron oxide Drugs 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 239000012811 non-conductive material Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000000751 protein extraction Methods 0.000 description 1
- 230000005588 protonation Effects 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000935 solvent evaporation Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000001269 time-of-flight mass spectrometry Methods 0.000 description 1
- 238000006276 transfer reaction Methods 0.000 description 1
- 239000000107 tumor biomarker Substances 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Classifications
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J49/00—Particle spectrometers or separator tubes
- H01J49/02—Details
- H01J49/04—Arrangements for introducing or extracting samples to be analysed, e.g. vacuum locks; Arrangements for external adjustment of electron- or ion-optical components
- H01J49/0409—Sample holders or containers
- H01J49/0418—Sample holders or containers for laser desorption, e.g. matrix-assisted laser desorption/ionisation [MALDI] plates or surface enhanced laser desorption/ionisation [SELDI] plates
Definitions
- the present invention relates to a matrix-assisted laser desorption ionization (MALDI) target plate, comprising a conductive substrate covered with patterns of nanoparticles with a large hydrophilic surface area.
- MALDI matrix-assisted laser desorption ionization
- MALDI is a soft ionization technique used in mass spectrometry (MS), allowing analysis of biomolecules (such as DNA, proteins, peptides and sugars) 1 and large organic molecules (such as polymers and dendrimers) 2 , which are fragile and easily fragmented when ionized by other ionization methods.
- MS mass spectrometry
- MALDI is similar in character to electrospray ionization (ESI) in that both techniques use relatively soft ways of obtaining ions of large molecules in the gas phase, though MALDI produces far fewer multiply charged ions.
- the sample is mixed or overlaid with a solution of a matrix that is commonly a crystallised organic acid, acting as a light absorber and a charge carrier. After drying, the sample co-crystallises with the matrix and retains its integrity.
- the principle of MALDI ionization lies in the absorption of laser energy by the matrix (typically UV laser e.g., 337 or 355 nm), which transfers the energy to the sample and facilitates its desorption and ionization by protonation or de-protonation. 4
- the ions are then accelerated at a fixed potential, and then separated from each other on the basis of their mass-to-charge ratio (m/z).
- the charged sample is then detected and measured using one or more of mass analysers, for example quadrupole mass analysers, ion trap analysers, time of flight (TOF) analysers, etc. 5
- MALDI-TOF MS has emerged as a potential tool for analysis of biological samples such as bacteria, fungi, yeasts, viruses, tissues and cancer cells. 6 8 Due to its ability to provide information about biomolecules, such as lipids, proteins, peptides, nucleic acids and metabolites, MALDI-TOF MS has been applied for characterization and identification of micro-organisms, epidemiological studies, tissue imaging, detection of biological warfare agents, and biomarker detection, and is a powerful tool for clinical diagnosis and treatment. For example, MALDI-TOF MS has been used for bacterial identification at the genus, species and even strain levels since the pioneer work of Holland et al., 9 Claydon et al. 10 and Krishnamurthy et al. 11 in 1996. Accordingly, commercial systems, such asMALDI Biotyper ® CA (Bruker Daltonics) and VITEK ® MS (bioMerieux) have been developed for routine identification of bacteria in clinical and microbiology laboratories.
- Biological entities can be analysed by MALDI-TOF MS directly in their intact/whole state or after "preparatory" component extraction, depending on their envelope structure.
- the approach of intact sample analysis is conducted by directly spotting the sample onto a MALDI target plate and overlaying it with matrix solution. Such is the case for bacteria like Neisseria spp., Yersinia spp., and Vibrio spp., where the bacterial cells are directly physically disrupted during MS measurements. 12 ' 13 This intact sample analysis procedure is simple and fast; however, it is not always efficient.
- micro-organisms e.g., viruses, bacterial spores, yeast cells
- a combination of formic acid and acetonitrile has often been used to extract proteins from bacterial cells for MS fingerprinting.
- Matsuda et al. 15 compared the performance of both procedures for Staphylococcus spp. identification. They showed that 60.2% and 80.8% of 273 clinical strains were identified with the intact bacteria profiling method and the "preparatory" protein extraction method, respectively, while the mean process time required for 48 duplicates was 30 min for the former and 180 min for the latter.
- MALDI matrix is often dissolved in a mixture of water, organic solvents (e.g., ethanol, methanol, acetonitrile) and a strong acid (e.g., trifluoroacetic acid).
- organic solvents e.g., ethanol, methanol, acetonitrile
- a strong acid e.g., trifluoroacetic acid.
- the most frequently used matrices for biological samples are a-cyano-4- hydroxycinnamic acid (CHCA), 2,5-dihydroxy benzoic acid (DHB), and 3,5- dimethoxy-4-hydroxycinnamic acid (sinapinic acid, SA). 17
- CHCA 2,5-dihydroxy benzoic acid
- SA 3,5- dimethoxy-4-hydroxycinnamic acid
- CHCA is more suitable for detection of low molecular weight molecules such as peptides and small proteins ( ⁇ 10,000 Da); DHB is more often used for phospholipids, glycopeptides and glycoproteins ( ⁇ 10,000 Da); while SA seems to be the best choice for large proteins (> 15,000 Da).
- metal oxides e.g., TiO 2 , ZnO, ZrO 2 , SnO 2
- metal oxides doped with different metal ions e.g., Au, Ag, Co
- Their photocatalytic activity is based on their unique electronic structure, which is characterized by a filled valence band and an empty conduction band.
- metal oxide particles Upon absorption of photons from the light source, metal oxide particles generate electron-hole pairs and act as photosensitizers, which drive efficient electron-transfer reactions on their surface and produce reactive oxygen species such as hydroxyl radical ("OH), superoxide radical ( * O 2 ⁇ ), and singlet oxygen ( 1 O 2 ).
- OH hydroxyl radical
- * O 2 ⁇ superoxide radical
- singlet oxygen 1 O 2
- Nanostructures have also been used to fabricate MALDI target plates.
- the term “nanostructures” refers to structures with nanoscale size (1 - 1000 nm) in at least one dimension.
- Niu et l. 26 have proposed to produce a nanostructured thin film (such as an alumina or aluminium thin film) on a supporting plate for MALDI MS analysis of proteins, peptides, small molecules, etc.
- the nanostructured thin film was used to generate enhanced surface area and the appropriate structural dimensions.
- the present invention provides a target plate according to claim 1, for enhanced MALDI MS analysis of intact biological entities such as bacteria, fungi, yeasts, virus, tissues and cancer cells.
- the target plate comprises an electrically conductive substrate partially covered with sintered photo-reactive nanoparticles, which provide a hydrophilic surface area for homogenous sample distribution.
- the nanoparticles absorb energy from the laser to generate electron-hole pairs and act as photosensitizers. They drive electron- transfer and radical reactions and cause in-source photo-electrochemical disruption of the biological entities' envelope structure, as well as assisting in desorption and ionization of components from the entities.
- the invention can be applied for characterization and identification of micro-organisms, analysis of micro-organisms' resistance to antibiotics, detection of biomarkers, imaging of tissues, etc., and serve for quick clinical diagnosis and treatment.
- the invention also provides a method of preparing a plate, according to claim 9, and a method of use of a plate, according to claim 13.
- Optional features of the invention are set out in the dependent claims.
- Fig. 1 schematically shows a photo-reactive MALDI plate for enhanced MS analysis of intact biological entities according to the invention
- Fig. 2 shows the mass spectra of intact gram-negative bacteria Escherichia coli (E.coli) obtained using a classic bare metallic MALDI plate and a MALDI plate presented in Fig. 1;
- Fig. 3 shows the mass spectra of intact gram-positive bacteria Bacillus subtilis (B. subtilis) obtained using a classic bare metallic MALDI plate and a MALDI plate presented in Fig. 1;
- Fig. 4 shows the mass spectra of intact human melanoma cancer line wmll5 obtained using a classic bare metallic MALDI plate and a MALDI plate presented in Fig. 1;
- Fig. 5 shows the mass spectra obtained from ampicillin-resistant E.coli XL1 and ampicillin-susceptible E.coli XL1 by using a classic bare metallic MALDI plate and a MALDI plate presented in Fig. 1;
- Fig. 6 shows the mass spectra obtained from kanamycin-resistant E.coli BL21 and kanamycin-susceptible E.coli BL21 by using a classic bare metallic MALDI plate and a MALDI plate presented in Fig. 1;
- Fig. 7 shows the mass spectra obtained from melanoma cell line wmll5 with or without the expression of green fluorescent protein by using a classic bare metallic MALDI plate and a MALDI plate presented in Fig. 1.
- Fig. 1 shows a MALDI plate comprising an electrically conductive substrate 1, partially covered with immobilized photo-reactive nanoparticles 2. Nanoparticles
- a whole detection process is conducted as following: z) a sample of biological entities 3 (e.g., bacteria, fungi, yeasts, viruses, cancer cells, tissues) in their intact state is placed on the plate in contact with the nanoparticles 2, which provide a hydrophilic surface area for the homogenous sample distribution; ii) a light-sensitive organic matrix 4 is added after the sample 3 is dried at room temperature; Hi) upon irradiation by laser 5, photo-reactive nanoparticles 2 absorb the laser energy, generate electron-hole pairs and trigger redox and radical reactions.
- the envelope structure of the intact biological sample e.g., bacteria, fungi, yeasts, viruses, cancer cells, tissues
- the substrate can be a commercially available MALDI plate or a homemade target plate made of any conducting material.
- the target plate is made of aluminium, nickel, stainless steel or a conductive polymer. It can present a flat, unmodified surface, or a surface with patterned spots, dots or annular groves to assist in locating samples.
- the substrate can be made of a non- conductive material coated with a thin layer of conductive material such as one or more evaporated metals, or a semi-conducting material.
- the conducting substrate can be a metallic foil placed in contact with a commercially available MALDI plate. A foil with a thickness below 250 ⁇ is suitable, such as commercially available aluminium foil used for cooking or packaging food.
- Drops of a nanoparticle suspension are deposited on substrate 1 to form a specific area, such as a set of stripes or an array of spots.
- a specific area such as a set of stripes or an array of spots.
- the array of spots allows a high throughput analysis of biological samples and is convenient for accurate positioning of samples.
- inkjet printing, screen-printing, rotogravure printing or other deposition techniques can be used to prepare the specific area of nanoparticles.
- Several layers of a nanoparticle suspension can be deposited on the substrate to form areas of different thicknesses, ranging from 50 nanometers to 50 micrometres. After the solvent evaporation, the particles can be sintered to ensure their mutual adhesion and adhesion to the substrate.
- Sintering can be performed either by thermally heating the nanoparticles below their melting point or by low- thermal techniques such as photonic flash sintering.
- the sintered nanoparticles provide a mesoporous structure with an extremely high surface-to-volume ratio and a high hydrophilic surface for homogeneous distribution of samples.
- the nanoparticles can be metal oxides (e.g., Ti0 2 , ZnO, Zr0 2/ Sn0 2 ), metal oxides doped with different metal ions (e.g., Au, Ag, Co) and other materials with photo- catalytic activity. It is important that the band gap of the nanoparticles matches the laser wavelength in the MALDI mass spectrometer.
- the sample can include whole or intact micro-organisms (e.g., bacteria, fungi, yeasts, virus), cells (e.g., cancer cells), tissues, or any other biological entities. If the sample is suspended in a liquid solution it can be deposited dropwise on the plate. If the sample is in a solid state it can be directly placed on the plate.
- micro-organisms e.g., bacteria, fungi, yeasts, virus
- cells e.g., cancer cells
- tissues e.g., or any other biological entities.
- the light sensitive organic matrix 4 can be a classic MALDI matrix containing usually a crystalline acid, such as a-cyano-4-hydroxycinnamic acid (CHCA), sinapic acid (SA), 2,5-dihydroxybenzoic acid (DHB) or 2-(4-hydroxyphenylazo)- benzoic acid (HABA).
- a crystalline acid such as a-cyano-4-hydroxycinnamic acid (CHCA), sinapic acid (SA), 2,5-dihydroxybenzoic acid (DHB) or 2-(4-hydroxyphenylazo)- benzoic acid (HABA).
- CHCA a-cyano-4-hydroxycinnamic acid
- SA sinapic acid
- DVB 2,5-dihydroxybenzoic acid
- HABA 2-(4-hydroxyphenylazo)- benzoic acid
- the gist of the present invention is to use photo-reactive nanoparticles for in- source photo-electrochemical disruption of the envelope of intact biological entities and for desorption/ ionization of the entities' components in the presence of an organic matrix.
- Samples are homogeneously distributed and adsorbed on the hydrophilic surface of nanoparticles. Under the irradiation of a pulsed laser light, the nanoparticles absorb energy from the laser, generate electron-hole pairs, and induce electron-transfer and radical reactions. These reactions cause break-up of the analysed entities, facilitating desorption and ionization of inner components together with the assistance of the matrix.
- Fig. 2 shows the comparison of mass spectra obtained from intact gram-negative bacteria E.coli by using a classic stainless steel MALDI plate and a photo-reactive MALDI plate from Fig. 1 where the immobilized nanoparticles 2 are ⁇ 1 ⁇ 2.
- Sinapinic acid was used as the organic matrix.
- Fig. 2a is in the mass range m/z 6,000 - 15,000 and Fig. 2b is for m/z 15,000 - 34,000.
- the obtained results show that the photo-reactive MALDI plate brings more relevant information from intact gram-negative bacteria.
- Fig. 3 shows the comparison of mass spectra obtained from intact gram-positive bacteria B.subtilis by using a classic stainless steel MALDI plate and a photo- reactive MALDI plate from Fig. 1 where the immobilized nanoparticles 2 are T1O2.
- Sinapinic acid was used as the organic matrix.
- Fig. 3a is in the mass range m/z 6,000 - 12,000 and Fig. 3b is for m/z 12,000 - 34,000.
- the obtained results show that photo-reactive MALDI plate brings more relevant information from intact gram- positive bacteria.
- Figs. 2 and 3 imply that identification of bacteria on the basis of protein fingerprinting can be significantly improved by using the present invention, especially at high mass range (m/z > 10,000).
- Fig. 4 shows the comparison of mass spectra obtained from the intact human melanoma cell line ivmll5 by using a classic stainless steel MALDI plate and a photo-reactive MALDI plate from Fig. 1 where the immobilised nanoparticles 2 are T1O2.
- Sinapinic acid was used as the organic matrix.
- Fig. 4a is in the mass range m/z 5,000 - 15,000 and Fig. 4b is for m/z 15,000 - 50,000.
- the obtained results show that more peaks can be obtained with the photo-reactive MALDI plate, implying that more components, especially with high molecular weight (> 10,000 Da) can be detected from intact cancer cells with the present invention.
- Fig. 5 compares the performance of a classic stainless steel MALDI plate (Fig. 5a) and a plate from Fig. 1 where the nanoparticles 2 are ⁇ 2 (Fig. 5b) for detection of bacterial resistance to ampicillin.
- the mass spectrum obtained from ampicillin-resistant E.coli XL1 was compared with that from ampicillin-susceptible E.coli XL1 at the mass range of m/z 27,800 - 29,800.
- Sinapinic acid was used as the organic matrix.
- the ampicillin-resistance gene expressed as a protein of 28,970 Da, was detected from the resistant strain using the invented plate (Fig. 5b), whereas this gene is undetectable using a classic bare MALDI plate (Fig. 5a).
- Fig. 6 compares the performance of a classic stainless steel MALDI plate (Fig. 6a) and a plate from Fig. 1 where the immobilised nanoparticles 2 are Ti0 2 (Fig. 6b) for detection of bacterial resistance to kanamycin.
- Fig. 6a and Fig. 6b the mass spectrum obtained from kanamycin-resistant E.coli BL21 was compared with that from kanamycin-susceptible E.coli BL21 at the mass range of m/z 19,000 - 20,000.
- Sinapinic acid was used as organic matrix.
- the kanamycin-resistance gene expressed as a protein of 29,050 Da, was detected from the resistant strain with the invented plate (Fig.
- Fig. 7 compares the performance of a classic stainless steel MALDI plate (Fig. 7a) and a plate from Fig. 1 where the immobilized nanoparticles 2 are Ti0 2 (Fig. 7b), for detection of a specific marker from cancer cells. In both Fig. 7a and Fig.
- the invented device can produce highly reproducible results, as the disruption process of the entities depends only on the photo-reactive nanomaterial.
- this invention provides a quick way of precise profiling of biological entities with high reproducibility. It therefore helps to broaden the applications of MALDI MS for biochemical research and clinical medicine.
- a ⁇ 1 ⁇ 2 suspension is prepared by dissolving a commercially available T1O2 paste (Solaronix Ti-Nanoxide D20/SP, Switzerland, 20 - 25 nm anatase nanoparticles; suspension Visopropanoi/Vwater/VTriton x-100 78/19.5/2.5) to reach a final concentration of 0.2 % (m/ m).
- T1O2 paste Small Organic Chemical Vapent
- the T1O2 suspension can also be screen-printed, rotogravure-printed, or directly deposited with a micropipette (1-10 ⁇ ,) onto the metal substrate.
- Bacteria e.g., E.coli, B.sutilis
- antibiotics e.g., ampicillin, carbenicillin, kanamycin, chloramphenicol, gentamicin, spectinomycin, erythromycin, hygromycin, tetracycline, etc.
- the solution (1 - 2 L) is deposited with a micropipette onto a spot on the Ti02-modified target plate, and dried at room temperature ( ⁇ 5 min).
- Matrix solution (1 - 2 uL, sinapinic acid, 15 mg/mL in Vacetonitriie/Vwater/ Vtrifluoroacetic acid 50/ 49.5/0.1) is added to cover the bacteria sample spot and dried at room temperature ( ⁇ 5 min).
- MALDI-TOF MS detection was performed on a Bruker microflex ® LRF under linear positive mode.
- the laser source used in this instrument is a nitrogen laser (337.1 nm).
- One mass spectrum is obtained from each sample spot by accumulation of 500 laser shots. Each test is repeated for 3 times and the average mass spectrum is presented in all figures.
- Non-pathogenic gram-negative E.coli and gram-positive B.subtilis are used as models to investigate the performance of the invented T1O2-MALDI plate for intact bacteria profiling and compare it with a classic bare MALDI plate. Results show that more peaks are obtained from the invented T1O2-MALDI plate, especially at the mass range > 10,000 Da, as shown in Fig. 2 and Fig. 3.
- the bacterial envelope is mainly composed of lipid bilayers and peptidoglycan, which can be broken up by TiO2-induced photo-chemical redox reactions.
- the ⁇ 2 nanoparticles also facilitate desorption and ionization of inner components together with the presence of organic matrix. Accordingly, more information about the internal components can be produced by the T1O2-MALDI plate directly from intact bacteria.
- Antibiotic-resistant bacteria often contain special resistance genes in their genome or on plasmids, which they have acquired from other bacteria and which they can spread to make non-resistant bacteria resistant to specific antibiotic compounds. Such antibiotic resistance genes encode proteins that perform enzymatic reactions to degrade or modify antibiotic molecules making them non-functional. These proteins conferring resistance to antibiotics normally appear in the mass range higher than 10,000 Da. Ampicillin and kanamycin resistance of E.coli are firstly analysed as models. As shown in Fig. 5b, compared to the ampicillin-susceptible E.coli XLl-blue strain, an additional peak at m/z 28,970 is detected from the ampicillin-resistant strain, by using the invented Ti02-MALDI plate.
- E.coli strains In addition to ampicillin and kanamycin, the resistance of E.coli strains to other antibiotics (e.g. carbenicillin, chloramphenicol, gentamicin, spectinomycin, erythromycin, hygromycin, tetracycline, etc.) can also be detected by the invented plate from intact bacteria.
- antibiotics e.g. carbenicillin, chloramphenicol, gentamicin, spectinomycin, erythromycin, hygromycin, tetracycline, etc.
- the human melanoma cell line wmll5 is employed as model.
- a cell pellet is collected from culture media by centrifugation (2,000 rpm x 4 min), and resuspended in the same volume of deionized water.
- the solution (1 pL) is deposited onto a T1O2 spot on the target plate and dried at room temperature.
- the cells are covered by 1 iL of matrix solution (sinapinic acid, 15 mg/ mL in Vacetonitriie/Vwater/Vtrifiuoroacetic acid 50/49.5/0.1) and dried at room temperature prior MALDI MS detection. MS measurements are similar to those of Example 1.
Landscapes
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
L'invention concerne une plaque cible pour une analyse par spectrométrie de masse à désorption/ionisation laser assistée par matrice améliorée (MALDI MS) d'entités biologiques intactes. La plaque cible comprend un substrat électroconducteur 1 recouvert au moins partiellement de nanoparticules photo-réactives immobilisées 2, servant de photosensibilisateur et d'un dispositif d'ionisation, qui entraîne des réactions de transfert d'électrons et de radicaux efficaces provoquant une perturbation interne de la structure d'enveloppe d'entités biologiques intactes 3 et aide à la désorption/ionisation de composants tels que des lipides, des peptides et des protéines à partir des entités biologiques intactes vers l'analyseur par spectrométrie de masse à désorption/ionisation laser assistée par matrice améliorée (MALDI MS).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1700908.5 | 2017-01-19 | ||
GBGB1700908.5A GB201700908D0 (en) | 2017-01-19 | 2017-01-19 | Maldi device and methods of preparation and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2018134232A1 true WO2018134232A1 (fr) | 2018-07-26 |
Family
ID=58462970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2018/051080 WO2018134232A1 (fr) | 2017-01-19 | 2018-01-17 | Dispositif maldi et procédés de préparation et d'utilisation associés |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201700908D0 (fr) |
WO (1) | WO2018134232A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023157352A1 (fr) * | 2022-02-16 | 2023-08-24 | 浜松ホトニクス株式会社 | Support d'échantillon, procédé d'ionisation et procédé de spectrométrie de masse |
CN117074503A (zh) * | 2023-10-16 | 2023-11-17 | 成都泰莱医学检验实验室有限公司 | 用于飞行时间质谱检测的纳米复合材料及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060145068A1 (en) * | 2004-12-30 | 2006-07-06 | Yu-Chie Chen | Metal oxide-assisted laser desorption/ionization mass spectrometry |
WO2006118595A2 (fr) * | 2004-09-17 | 2006-11-09 | Nanosys, Inc. | Films fins nanostructures et utilisations associees |
WO2009003673A2 (fr) * | 2007-07-02 | 2009-01-08 | École Polytechnique Fédérale de Lausanne | Extraction sur phase solide et dispositif d'ionisation |
-
2017
- 2017-01-19 GB GBGB1700908.5A patent/GB201700908D0/en not_active Ceased
-
2018
- 2018-01-17 WO PCT/EP2018/051080 patent/WO2018134232A1/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006118595A2 (fr) * | 2004-09-17 | 2006-11-09 | Nanosys, Inc. | Films fins nanostructures et utilisations associees |
US20060145068A1 (en) * | 2004-12-30 | 2006-07-06 | Yu-Chie Chen | Metal oxide-assisted laser desorption/ionization mass spectrometry |
WO2009003673A2 (fr) * | 2007-07-02 | 2009-01-08 | École Polytechnique Fédérale de Lausanne | Extraction sur phase solide et dispositif d'ionisation |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023157352A1 (fr) * | 2022-02-16 | 2023-08-24 | 浜松ホトニクス株式会社 | Support d'échantillon, procédé d'ionisation et procédé de spectrométrie de masse |
CN117074503A (zh) * | 2023-10-16 | 2023-11-17 | 成都泰莱医学检验实验室有限公司 | 用于飞行时间质谱检测的纳米复合材料及其制备方法 |
CN117074503B (zh) * | 2023-10-16 | 2024-01-26 | 成都泰莱医学检验实验室有限公司 | 用于飞行时间质谱检测的纳米复合材料及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
GB201700908D0 (en) | 2017-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bouschen et al. | Matrix vapor deposition/recrystallization and dedicated spray preparation for high‐resolution scanning microprobe matrix‐assisted laser desorption/ionization imaging mass spectrometry (SMALDI‐MS) of tissue and single cells | |
TWI434314B (zh) | 質譜用基材、質譜術、以及質譜儀 | |
US6617575B1 (en) | Modified ion source targets for use in liquid maldi MS | |
US6995363B2 (en) | Reduction of matrix interference for MALDI mass spectrometry analysis | |
Naito et al. | A novel laser desorption/ionization method using through hole porous alumina membranes | |
Sonderegger et al. | Surface-assisted laser desorption/ionization-mass spectrometry using TiO 2-coated steel targets for the analysis of small molecules | |
McEwen et al. | An alternative ionization paradigm for atmospheric pressure mass spectrometry: flying elephants from Trojan horses | |
CN103592361B (zh) | 一种二硫化钨在激光解吸电离质谱检测中的应用 | |
Hsu et al. | Desorption ionization of biomolecules on metals | |
US20100248388A1 (en) | Solid Phase Extraction and Ionization Device | |
US8217340B2 (en) | Mass spectrometry substrate and mass spectrometry method | |
US9799501B2 (en) | Sample mounting plate | |
US20210343518A1 (en) | Multi-mode ionization apparatus and uses thereof | |
KR101592517B1 (ko) | 레이저 탈착 이온화 질량 분석용 기판 및 그 제조방법 | |
US9709583B2 (en) | MALDI/SELDI analysis of complex mixtures comprising hydrophilic and hydrophobic analytes | |
Lee et al. | Nanoengineered micro gold shells for LDI-TOF analysis of small molecules | |
JP5317054B2 (ja) | 質量分析用基板及びその製造方法並びに質量分析法 | |
US8080784B2 (en) | Ionization device | |
CN107167512A (zh) | 用于基质辅助激光解吸离子化质谱仪的一次性靶板 | |
WO2018134232A1 (fr) | Dispositif maldi et procédés de préparation et d'utilisation associés | |
Kuwata et al. | DIUTHAME enables matrix‐free mass spectrometry imaging of frozen tissue sections | |
Kosyakov et al. | Carbon nanocoatings: A new approach to recording mass spectra of low-molecular compounds using surface-assisted laser desorption/ionization mass spectrometry | |
JP6363527B2 (ja) | 試料積載プレート | |
US9552972B2 (en) | Method for ion production | |
Kononikhin et al. | Signal enhancement in electrospray laser desorption/ionization mass spectrometry by using a black oxide-coated metal target and a relatively low laser fluence |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18700759 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18700759 Country of ref document: EP Kind code of ref document: A1 |